ABSTRACT Background: Zonulin is a newly discovered protein that has an important role in the regulation of intestinal permeability. Our previous study showed that probiotics can decrease the rate of infectious complications in patients undergoing colectomy for colorectal cancer. Objective: The objective was to determine the effects of the perioperative administration of probiotics on serum zonulin concentrations and the subsequent effect on postoperative infectious complications in patients undergoing colorectal surgery. Design: A total of 150 patients with colorectal carcinoma were randomly assigned to the control group (n = 75), which received placebo, or the probiotics group (n = 75). Both the probiotics and placebo were given orally for 6 d preoperatively and 10 d postoperatively. Outcomes were measured by assessing bacterial translocation, postoperative intestinal permeability, serum zonulin concentrations, duration of postoperative pyrexia, and cumulative duration of antibiotic therapy. The postoperative infection rate, the positive rate of blood microbial DNA, and the incidence of postoperative infectious complications-including septicemia, central line infection, pneumonia, urinary tract infection, and diarrhea-were also assessed. Results: The infection rate was lower in the probiotics group than in the control group (P , 0.05). Probiotics decreased the serum zonulin concentration (P , 0.001), duration of postoperative pyrexia, duration of antibiotic therapy, and rate of postoperative infectious complications (all P , 0.05). The p38 mitogen-activated protein kinase signaling pathway was inhibited by probiotics. Conclusions: Perioperative probiotic treatment can reduce the rate of postoperative septicemia and is associated with reduced serum zonulin concentrations in patients undergoing colectomy. We propose a clinical regulatory model that might explain this association. This trial was registered at http://www.chictr.org/en/ as ChiCTR-TRC-00000423.
INTRODUCTION
With the development of advanced surgical techniques and improved perioperative care, rates of postoperative morbidity and mortality in patients undergoing gastrointestinal surgery have been considerably reduced (1) (2) (3) . Meanwhile, postoperative infectious complications, such as urinary tract infections, pneumonia, wound infection, intraabdominal abscess, and cholangitis, occur increasingly commonly after abdominal surgery. These complications not only lead to a prolonged duration of postoperative pyrexia and the cumulative duration of antibiotic therapy but also cause long hospital stays, high costs, and significant distress (1, 4, 5) . These complications can lead to higher rates of recurrence and significant death rates (1, 6) .
It has been reported that probiotics can play an important role on the stability of the microbiological environment (7) (8) (9) . In recent decades, several randomized trials have been conducted regarding the protective effects of pre-and postoperative probiotic therapy in surgical patients (10) (11) (12) , which indicated that the perioperative use of probiotics significantly improved intestinal microbial populations, reduced intestinal permeability, reduced the incidence of further infectious complications, improved the quality of life of patients, and shortened the duration of postoperative hospital stay and antibiotic administration (1, 13) . However, no studies have explored the link between intestinal permeability and rates of postoperative infectious complications, and the precise role of probiotics in this process has not been elucidated.
As a protein that participates in tight junctions between cells of the wall in the digestive tract, zonulin was initially discovered in 2000 as the target of zonula occludens toxin (Zot) the cholera pathogen Vibrio cholerae (14) . Recently, zonulin was found to reflect intestinal permeability (14) . Because intestinal permeability may have an effect on the incidence of postoperative infectious complications, we proposed the hypothesis that pre-and postoperative probiotic use may reduce intestinal permeability, lower the rate of bacterial translocation (BT), and decrease the rate of postoperative infectious complications after surgery for colorectal cancer. In the current study, we aimed to investigate the effects of the perioperative administration of probiotics on serum zonulin concentrations, intestinal permeability, and the subsequent effect on postoperative infectious complications in patients undergoing colorectal surgery.
SUBJECTS AND METHODS

Inclusion and exclusion criteria
The following inclusion criteria were used for patients in this study: 1) age between 25 and 75 y, 2) a diagnosis confirmed by biopsy and histologic testing, and 3) radical resection previously performed, and 4) no distant metastasis. The exclusion criteria were as follows: 1) age .75 y, 2) pregnancy, 3) known lactose intolerance, 4) clinically significant immunodeficiency, 5) additional gastrointestinal disorders (eg, Crohn disease or ulcerative colitis), 6) use of antibiotics during the 10 d before surgery, 7) evidence of infection, 8) use of other pre-or probiotic or excessive fiber intake within 2 wk of surgery, 9) history of an emergency operation, 10) bowel preparation for colonoscopy within 6 d before surgery, 11) history of a proctectomy with low rectal anastomosis or surgery for a polypoid lesion, 12) previous laparoscopic surgery, 13) receipt of preoperative neoadjuvant chemotherapy or radiotherapy, and 14) distant metastasis.
Patients
Overall, 161 patients with colorectal cancer who were scheduled to undergo a radical colectomy at 1 of 2 centers-the Shanghai Sixth People's Hospital, affiliated with Shanghai JiaoTong University in Shanghai, and the Sixth Affiliated Hospital of Sun Yat-sen University in Guangzhou-between April 2007 and December 2011 were enrolled in this study. The patients were randomly assigned before surgery to either the placebo group (control) to receive perioperative oral feeding with a placebo or the probiotics therapy group to receive probiotic treatment perioperatively. The study design and protocols were reviewed and approved by the Human Research Review Committee in both the Shanghai Sixth People's Hospital and the Sixth Affiliated Hospital of Sun Yat-sen University, and written informed consent for participation was obtained from each patient before their enrollment into the study.
In our study, 168 patients were assessed for eligibility, whereas only 161 patients were enrolled as 7 patients were excluded. They either did not meet the inclusion criteria or refused to participate. Only 138 of the patients completed the entire study. Of the 161 patients, 80 were included in the control group, whereas 81 were in the probiotics group. Of the 138 subjects who completed the trial (Figure 1 ), 68 were in the control group and 70 in the probiotics group. No significant differences in sex (male/female), age (y), BMI (kg/m 2 ), cancer stage (Duke's A, B, or C), or time between the onset of symptoms and hospital admission (d) were found between the 2 groups. Also, no significant difference was found in the preoperative serum concentrations of albumin (g/dL), hemoglobin (g/L), and creatinine (mg/dL) and operative time (min), intraoperative blood loss (mL), intraoperative transfusion (mL), use of supplemental albumin postoperatively (g), and preoperative preparation time (d), and supplementation with metronidazole, penicillin, and ceftriaxone was the same between both groups; data for the intention-to-treat population are shown in Table 1 and for the per-protocol population are shown elsewhere (see Table S1 under "Supplemental data" in the online issue).
Study design, probiotic treatment, and patient care
Random assignment to the 2 groups was accomplished by using a computer-generated random allocation schedule. The treatment assignment was only known to a nurse who was not FIGURE 1. Flowchart of the randomization procedure used to enroll patients in the study. PRO, probiotics. directly involved in the trial and who could have broken the treatment codes in the event of an emergency.
Patients in the probiotics group received the daily encapsulated admixture of 3 probiotics bacteria (Institute of Life Science of Only, Shanghai Jiao Tong University, Shanghai, China), composed of Lactobacillus plantarum [CGMCC no.1258, cell count $10 11 colony forming units (CFU)/g), Lactobacillus acidophilus-11 (cell count $7.0 3 10 10 CFU/g), and Bifidobacterium longum-88 (cell count $5.0 3 10 10 CFU/g)]. An acid-resistant coating was used to prepare the capsules containing the probiotics and placebo. Each patient in the probiotics group received probiotics, 2 g/d, at a total daily dose of 2.6 3 10 14 CFU. Patients in the control group received encapsulated maltodextrin daily. The appearance of the 2 types of capsules and the smell and taste of the study substances were the same.
The intervention period lasted 16 d, ie, 6 d preoperatively and 10 d postoperatively. All of the subjects were interviewed by the study nurse, and any reactions to the product, medications taken and adverse events that occurred in the16-d period were recorded.
During the study period, no parenteral or enteral nutritional supplementation was given. All patients received a regular diet preoperatively and a low-residue diet 1 d preoperatively. Mechanical bowel preparation was given 1 d before the surgery: all patients were given Soffodex (CB Fleet Company Inc) containing 2.4 g monobasic sodium phosphate and 0.9 g dibasic sodium phosphate. Parenteral hydration was given on the morning of the surgery via a central venous catheter. A 12-F catheter was placed through a jejunal limb during surgery for gastric aspiration to reduce flow through the colon anastomosis. During the postoperative period, all patients received regular parenteral hydration infusion. For prophylaxis, 500 mg metronidazole and 1 g ceftriaxone were given 1 h before induction and continued for 48 h after surgery. Complications were registered daily postoperatively, and the patients were reexamined at the outpatient clinic 1, 2, and 4 wk after surgery.
We collected additional patient specimens and clinical data in the center of our previous study (12 patients in the control group and 13 patients in the probiotics group) and included a second center (the Sixth Affiliated Hospital of Sun Yat-Sen University) to determine the serum concentration of zonulin. The full data set is not independent of the first study (1) .
Mesenteric lymph node culture for bacterial translocation
Mesenteric lymph node samples were harvested after the mobilization of the gut tissues during laparotomy by using a fresh surgical blade. Samples were taken from the inferior mesenteric pedicle before its ligation, as previously described (1) . The mesenteric lymph node samples were divided equally into 2 parts for both histopathology and bacterial culture. Microbiological techniques were followed for bacterial culture and identification (15) (16) (17) . In brief, isolates grown on culture media were identified by their characteristic colonial and microscopic appearances and with the use of Analytical Profile Index 20E bacterial identification strips (Bio Merieux). Fungi were identified by the Auxacolor colorimetric identification system (Sanofi Diagnostics Pasteur) as previously described. 1 There were no significant differences in characteristics between the 2 groups. Numerical data between groups were compared by t test and nominal data by Pearson's chi-square test or Fisher's exact test.
2 Mean 6 SD (all such values).
Intestinal permeability assay
Intestinal permeability was assessed by using the lactulose/ mannitol (L/M) test preoperatively (the morning of the surgery) and on 3 and 10 d postoperatively, as previously described (1). After fasting overnight, all subjects were given the oral test solution containing 10 g lactulose (Sigma-Aldrich) and 5 g mannitol (Sigma-Aldrich) in 60 mL physiologic saline. For the next 6 h, the subjects rested, and no food or water was allowed. Complete 6-h urine samples were collected, and a further 10-mL urine sample was frozen at 220 8 C until analyzed. Urinary lactulose and mannitol concentrations were measured by gasliquid chromatography (1, 18) .
Measurements of colon mucosal short circuit current for transepithelial resistance and horseradish peroxidase flux to assess transepithelial permeability
The samples of the normal colonic segments were collected during surgery and immediately immersed in oxygenated Kreb's buffer; after they were stripped of external muscle and the myenteric plexus, the adjacent segments were mounted into an Ussing chamber (World Precision Instruments; Narco Scientific). With use of the chamber, 0.6 cm 2 tissue was exposed to 8 mL circulating oxygenated Kreb's buffer containing 115 mmol NaCl/L, 1.25 mmol CaCl 2 /L, 1.2 mmol MgCl 2 /L, 2.0 mmol KH 2 PO 4 /L, and 25 mmol NaHCO 3 /L (pH 7.35). The chambers contained agar-salt bridges to monitor the potential difference across the tissue and to inject the required short circuit current to maintain a zero potential difference, as recorded via an automated voltage clamp (World Precision Instruments). Tissue conductance, representing its passive permeability to ions, was calculated by U's law. Mucosal to serosal transport of macromolecules was assessed by measuring the transepithelial flux of horseradish peroxidase (HRP) as a model protein antigen. HRP activity was determined by using a modification of Worthington's method, and the mucosal to serosal flux of HRP was expressed as pmol/ h per cm 2 (1, 19) .
Measurement of serum zonulin concentration
The concentrations of serum zonulin 24 h postoperatively were measured by using an ELISA kit that selectively detected serum zonulin concentrations, as previously described (20) . Briefly, plastic microtiter plates (Costar) were coated with rabbit zonulin cross-reacting Zot derivative DG IgG antibodies (10 mg/mL in 0.1 mol sodium carbonate buffer/L, pH 9.0), which were generated according to previously described methods (20) . After an overnight incubation at 4 8 C, the plates were washed 4 times in Tris-buffered saline 0.05% Tween 20 (TBS-T) and blocked by incubation for 1 h at 37
8 C with TBS-T. After 4 TBS-T washes, 6 DG serial standards (50, 25, 12.5, 6.2, 3.1, and 0 ng/mL) and patient sera samples (1:101 dilution in TBS-T) were added and incubated overnight at 4 8 C. After 4 washes with Tris-buffered saline 0.2% Tween 20 buffer, plates were incubated with biotinylated anti-Zot IgG antibodies for 4 h at 4 8 C. A color reaction was developed by using a commercial kit (ELISA amplification kit; Invitrogen). The absorbance at 495 nm was measured with a microplate auto-reader (Molecular Devices Thermomax Microplate Reader).
Postoperative clinical observation of infectious complications
Our previous study had shown that postoperative clinical outcomes were significantly different, including central line infections, pneumonia, urinary tract infection, time to first defecation, diarrhea, abdominal cramping, abdominal distension, duration of postoperative pyrexia, and cumulative duration of antibiotic therapy (1) . We selected these infection-related variables and recorded their incidence for up to 30 d after surgery. Additionally, the duration of postoperative pyrexia and postoperative infectious complications (septicemia, central line infection, pneumonia, urinary tract infection, and diarrhea) were recorded. The diagnosis of bacterial infection was based on a previous reference (11) . Furthermore, the total hospital charge was compared between the 2 groups.
Microbiological investigations and polymerase chain reaction assay for bacterial DNA fragment
Clinical samples comprising blood (40 mL), central lines (tips), urine (20 mL), and sputum (all collected at 0600) were collected as previously described (1) . Each clinical sample was taken from patients w72 h after the operation and sent immediately to the microbiological laboratory in the Department of Medical Microbiology. The specimens were cultured aerobically as well as under microaerophilic conditions and anaerobically at 35-37 8 C for 24 to 48 h. Anaerobic cultivation was performed in anaerobic chambers. Fungal cultures were made with the use of Sabouraud's medium (bioMérieux, France). The biochemical characteristics of the cultured strains were investigated by using the Analytical Profile Index and/or identification tests (bioMérieux, France) according to the manufacturer's instructions. The remaining 20 mL blood was collected in a sterile container containing EDTA for the molecular detection of bacterial DNA. To determine the sensitivity of the polymerase chain reaction (PCR) detection, serial dilutions of the spiked blood were tested until a negative result was found. The sensitivity of the test was 10 organisms/mL. RNA extraction, cDNA synthesis, and real-time quantitative PCR Our previous study indicated that the p38 mitogen-activated protein kinase (MAPK) signaling pathway was involved in the protective process of intestinal permeability and intestinal barrier function (21) . Thus, we further determined intestinal p38 MAPK gene expression using real-time quantitative PCR, as previously described (20, 21) . Briefly, total RNA was extracted from the adjacent normal colorectal epithelium of 5 patients with colon cancer by using Trizol reagent (Invitrogen), according to the manufacturer's instructions, to detect the expression level of p38 MAPK. The quantity and quality of RNA was verified by the ratio of absorbance values at 260 and 280 nm and by visualization of the bands on agarose gels. For each sample, 600 ng mRNA was used in the reverse transcription reaction (iScript kit; BioRad Laboratories) according to the manufacturer's specifications. The mRNA levels of each group were further analyzed by real-time PCR with a light-cycling system (LightCycler; Roche Diagnostics GmbH). All values were expressed as a fold increase or decrease relative to the expression of actin. The sequences of the primers were as follows: p38 MAPK (F: 5#-GAAGAGCCTGACCTA-CGAT-3#; R: 5#-ACTGCCAAGGAGCATCTA-3#) and b-acting (F: 5#-CTCCATCCTGGCCTCGCTGT-3#; R: 5#-GCTGTCAC-CTTCACCGTTCC-3#).
Statistical analysis
A sample size calculation based on the published prevalence of BT demonstrated that w44 patients would be required in each group to demonstrate a reduction in BT from 15% to 0% at the 5% significance level with a power of 80% (22) 
RESULTS
Lower postoperative incidence of BT in the probiotics group
The results indicate that BT occurred in 21 of 75 patients (28%) in the control group and in 10 of 75 patients (13%) in the probiotics group in the intention-to-treat analysis. Statistical analysis showed that the probiotics group had a significantly lower postoperative incidence of BT than did the control group (P = 0.027; Figure 2A ). Similar results were indicated in the per-protocol analysis (P = 0.049; see Figure S1A under "Supplemental data" in the online issue).
Probiotics reduced postoperative intestinal permeability
In the intention-to-treat analysis, the L/M ratios were not significantly different between the 2 groups before treatment (0.160 6 0.058 and 0.155 6 0.066; P = 0.623). The preoperative L/M ratio was higher in the control group than in the probiotics group (0.196 6 0.062 and 0.156 6 0.052; P = 0.001). The L/M ratio in the control group was similar to that in the probiotics group 3 d after surgery (0.222 6 0.059 and 0.231 6 0.058, respectively; P = 0.348). Ten days postoperatively, the mean L/M ratio in the probiotics group (0.166 6 0.039) was significantly lower than that in the control group (0.216 6 0.061; P = 0.001; Figure 2B ). A direct correlation was found between the postoperative serum zonulin concentration and the L/M ratio (r = 0.504, P = 0.001). Similar results were indicated in the per-protocol analysis (see Figure S1B under "Supplemental data" in the online issue).
The mean colon mucosal transepithelial resistance (TER) in the control group (12.66 6 5.86 U/cm 2 ) was significantly lower than FIGURE 2. The incidence of bacterial translocation and intestinal permeability. A: The postoperative incidence of bacterial translocation was significantly lower in the PRO group (n = 75) than in the control group (n = 75). B: The ratio of lactulose to mannitol was lower in the control group (n = 75) than in the PRO group (n = 75) preoperatively and 10 d postoperatively, whereas no difference was found 3 d postoperatively. There was a direct correlation between the postoperative serum zonulin concentration and the ratio of lactulose to mannitol (r = 0.504, P , 0.01). The black bars represent the control group, and the gray bars represent the PRO group. C: The mean colon mucosal transepithelial resistance was higher in the PRO group (n = 5) than in the control group (n = 5). D: The cumulative transmucosal permeation of horseradish peroxidase into the colon mucosa over 120 min was lower in the PRO group (n = 5) than in the control group (n = 5). *Significantly different from the control group, P , 0.05. Quantitative data are expressed as means 6 SDs and were compared by using a t test and Pearson's chi-square test between groups. The ratio of lactulose to mannitol was determined preoperatively (on the morning of surgery) and 3 and 10 d postoperatively, whereas transepithelial resistance and horseradish peroxidase flux were determined 10 d postoperatively. PRO, probiotics. that in the probiotics group (19.21 6 6.02 U/cm 2 ; P = 0.001). The cumulative transmucosal permeation of HRP in the colon mucosa during 120 min in the control group (1.18% 6 0.29%) was significantly higher in the probiotics group than in the control group (0.62% 6 0.15%; P = 0.001; Figure 2 , C and D). An assessment of the correlation between postoperative serum zonulin concentrations and TER or HRP flux was performed by using Spearman's coefficient model. A direct correlation was found between the postoperative serum zonulin concentration and TER (r = 0.900, P = 0.037) and between the postoperative serum zonulin concentration and HRP flux (r = 1.000, P = 0.001).
Probiotics reduced the postoperative serum zonulin concentration
The serum zonulin concentration before treatment was not significantly different between the 2 groups (0.32 6 0.30 and 0.36 6 0.28 ng/mg protein; P = 0.545). The postoperative serum zonulin concentration in the control group (1.08 6 0.28 ng/mg protein) was significantly higher than that in the probiotics group (0.39 6 0.26 ng/mg protein; P = 0.001; Table 2 ). Similar results were indicated in the per-protocol analysis (see Table S2 under "Supplemental data" in the online issue).
Probiotics alleviated postoperative infectious complications
Postoperative infection-related variables were significantly different between the probiotics and control groups, which agreed with the findings of our previous study (1) . The incidence of postoperative septicemia was 73% (55/75) in the control group and 55% (41/75) in the probiotics group (P = 0.017). Further analysis found that the incidence of postoperative septicemia with high serum zonulin concentrations did not differ significantly between the control (86%, 51/59) and probiotics (86%, 30/35) groups (P = 0.921). The same result was found in the low serum zonulin group [25% (4/16) and 28% (11/40); P = 0.849]. When patients were 1 n or n/N in parentheses. Numerical data between groups were compared by t test and nominal data by Pearson's chisquare test or Fisher's exact test. HZ, high serum zonulin ($0.6 ng/mg protein); LZ, low serum zonulin (,0.6 ng/mg protein).
3 HZ compared with LZ (regardless of treatment): 86% compared with 27% (P = 0.001). There was a significant correlation between septicemia and zonulin (r = 0.634, P = 0.001).
4 HZ compared with LZ (regardless of treatment): 6.92 6 2.59 compared with 5.56 6 2.26 (P = 0.001). There was a significant correlation between duration of postoperative pyrexia and zonulin (r = 0.792, P = 0.001).
5 HZ compared with LZ (regardless of treatment): 7.38 6 2.19 compared with 5.58 6 2.29 (P = 0.001). There was a significant correlation between cumulative duration of antibiotic therapy and zonulin (r = 0.865, P = 0.001).
grouped according to serum zonulin concentration regardless of treatment group, the incidence of postoperative septicemia was significantly higher in the high serum zonulin (86%, 81/94) than in the low serum zonulin (27%, 15/56) group (P = 0.001; Table 2 ).
(Also see Table S2 under "Supplemental data" in the online issue.)
The duration of postoperative pyrexia and the cumulative duration of antibiotic therapy showed results similar to those of septicemia. A detailed comparison between the 2 groups is shown in Table 2 . Postoperative infectious complications, including central line infections, pneumonia, urinary tract infection, and diarrhea, differed significantly between the control and probiotics groups; however, when the incidences of these complications were compared in the high and low serum zonulin groups, no significant differences were found. The hospital charge was also compared in both groups, and these results indicated that patients treated with probiotics had a lower overall hospital charge than did the control group. Similar results were found in the perprotocol data. Furthermore, the incidence of postoperative septicemia was correlated with the serum zonulin concentration (r = 0.634, P = 0.001).
Probiotics reduced the postoperative infection rate and the blood microbial DNA positive rate
To determine the types of infectious bacteria and positive rate of microbial culture, we also determined bacterial DNA concentrations in the blood, central line tips, and sputum sample cultures. During the postoperative 72-h period, the total rate of positive bacterial cultures (including blood, central lines, and sputum) in the control group (31%, 23/75) was significantly higher than that in the probiotics group (16%, 12/75), as shown in Table 3 (P = 0.034). The positive rate of bacteria in blood cultures in the control group (13%, 10/75) was not significantly higher than that in the probiotics group (5%, 4/75; P = 0.092; Table 3 ). Microbial DNA was found in all patients whose blood cultures were positive. The rate of blood bacterial DNA positivity in the control group (25%, 19/75) was significantly higher than that in the probiotics group (11%, 8/75; P = 0.019). Furthermore, only 2 pathogens were detected in the blood samples: Escherichia coli and Staphylococcus aureus; E. coli was the most commonly identified bacteria in 83% of the samples with bacteria. Similar results were indicated in the per-protocol analysis (see Table S3 under "Supplemental data" in the online issue).
Probiotics inhibited the p38 MAPK signaling pathway
The p38 MAPK signaling pathway is involved in the protection of intestinal permeability and the intestinal barrier function (21) . To establish whether the probiotics treatment was associated with modification of the p38 MAPK signaling pathway, intestinal samples from adjacent normal tissues were obtained from colorectal carcinoma patients with or without probiotics treatment (n = 5 for each group). The results showed that the expression of p38 MAPK was lower in the probiotics group (1.58 6 0.59) than in the control group (2.49 6 0.58; P = 0.001).
DISCUSSION
Clinical trials regarding the effects of perioperative probiotics treatment on the outcomes of colorectal cancer have been rare (23) (24) (25) . However, in those 3 studies, no one has reported the relation between perioperative probiotics treatment and postoperative infectious complications in patients undergoing colorectal cancer surgery. Our pervious study indicated the use of perioperative probiotics to protect human intestinal barrier function and prevent postoperative infectious complications after colorectal cancer surgery (1). In our current study, we further collected additional patient specimens and clinical data in the center of our previous study and included a second center (the Sixth Affiliated Hospital of Sun Yat-Sen University) to determine the effect of serum concentrations of zonulin during the protection of probiotics on intestinal barrier. Furthermore, we proposed the novel concept of the clinical regulatory pathway (CP) as the mechanism by which a clinical treatment can cause a series of responses similar to a molecular signal transduction pathway. We hypothesize that CP may link molecular signals to clinical outcomes, to identify useful clinical biomarkers. Furthermore, the CP may lead to a greater broader understanding of the effects of newly identified or implicated molecules in a particular clinical disorder.
It has been reported that probiotics improve barrier function after Escherichia coli infection or incubation with proinflammatory cytokines (26, 27) . Our previous clinical trial (1) showed that probiotics can reduce intestinal permeability and reduce BT. Our current study also determined that intestinal permeability correlated with probiotics administration and postoperative clinical variables. Our current results showed that preoperative intestinal permeability was lower in the probiotics group than in the control group, and no difference was found 3 d after surgery between the 2 groups; however, by 10 d postoperatively, intestinal permeability decreased again and was significantly lower in the probiotics group. Therefore, we deduced that preoperative probiotics treatment reduced intestinal permeability until the day of surgery; however, operative stimulation may increase intestinal permeability, which reduces the effects of probiotics until 10 d postoperatively when the patient's recovery is underway. Because it has been reported that small intestinal paracellular permeability defects may contribute to increased rates of BT (28, 29) , and BT occurs more frequently in patients with intestinal barrier dysfunction (30, 31), we deduced that probiotics may inhibit the increase of postoperative intestinal permeability and then reduce the rate of postoperative BT (32) . Analysis of the concentration of postoperative serum zonulin indicated that probiotics decreased serum zonulin concentrations after surgery. Zonulin is a newly identified protein that can reflect intestinal permeability (14, 20, 33) . Our previous analysis also indicated a correlation between serum zonulin concentrations and the L/M ratio, TER, and HRP flux, which indicated that zonulin can be used as a biomarker of gut permeability. This novel finding indicated that probiotics may reduce the concentration of serum zonulin, inhibit the increase of postoperative intestinal permeability, reduce the postoperative BT rate, and improve clinical outcomes. Further analysis found that the incidence of postoperative septicemia was greater in the high serum zonulin group than in the low serum zonulin group, regardless of probiotics treatment. The correlation analysis also suggested a direct correlation between postoperative serum zonulin concentrations and the incidence of postoperative septicemia. The duration of postoperative pyrexia and the cumulative duration of antibiotic therapy also showed the same effects that suggest regulation by zonulin. Because postoperative septicemia caused by BT may prolong the duration of postoperative pyrexia and the corresponding duration of antibiotic therapy (34, 35) , the hospital charge also increases (36, 37) . Therefore, combined with the above findings, we deduced that the perioperative administration of probiotics may reduce postoperative zonulin concentrations, inhibit the incidence of BT, decrease postoperative septicemia, shorten the duration of postoperative pyrexia time and antibiotic therapy, and lower the overall hospital charge. The finding that E. coli was the main bacteria identified in blood samples further supports the notion that BT from the intestinal tract to the blood is the most important reason for postoperative septicemia (1, 38) .
p38 MAPK is a Ser/Thr kinase belonging to the family of MAPKs, which has been shown to be related to the expression level of several inflammatory genes, including inducible nitric oxide synthase, IL-8, and IL-6 (21). Our previous study also showed that the inhibition of p38 MAPK phosphorylation by the active component of probiotics exerted a protective effect on the intestinal barrier (21) . We hypothesized that the effects of probiotics were mediated via the p38 MAPK pathway and found an inhibitory effect of probiotics on the gene expression level of p38 MAPK. Therefore, we suggest that the perioperative administration of probiotics may inhibit the expression of p38 MAPK and consequently reduce the postoperative zonulin concentration. However, in the current study, we pointed out only one of the possible signal transduction pathways by which probiotics regulate zonulin expression. However, it is reasonable to assume that zonulin also plays a role in the regulation of the p38 MAPK pathway or in the regulation between P38 MAPK and zonulin, given similar signaling of the zonulin prokaryotic analog Zot (39) . More basic studies may be needed to prove this hypothesis. Above all, our CP of probiotics on postoperative septicemia in colorectal cancer surgery can be presented as probiotics/p38 MAPK/zonulin-intestinal permeability/BT/postoperative septicemia/duration of postoperative pyrexia and cumulative duration of antibiotic therapy/lower hospital charge as the CP of probiotics (Figure 3) .
The current study was limited by the fact that perioperative intestinal permeability could have been influenced by 3 factors: colorectal carcinoma, colectomy, and probiotics treatment. It is therefore difficult to tease out the exact contribution of probiotics without using a larger number of patients. In addition, during the comparison of the postoperative clinical variables, the distribution of patients in the high or low serum zonulin group was not uniform. Therefore, further studies should be performed to exclude the influence of these factors on our results. We found no significant difference (P . 0.05) in L/M ratios and serum zonulin concentrations before treatment between the 2 groups. However, other indicators, such as the colon mucosal short circuit current for TER and HRP flux, could not be determined before treatment, which may have been a limitation. There was a direct correlation between the postoperative serum zonulin concentration and HRP flux (r = 1.000, P , 0.01), and the correlation between the postoperative serum zonulin concentration and TER (r = 0.900, P = 0.037) was significant. Therefore, the results were both statistically significant and clinically important.
In general, assessment of numerous outcome variables gives rise to a multiple comparison issue, especially regarding marginally significant results, which should be viewed with a degree of caution. However, the overall consistency of findings across outcomes lends support to the effectiveness of treatment with probiotics (1). The comparison of treatments between the high and low serum zonulin groups was limited by a small sample size and not by randomization issues, which may have been a limitation.
In conclusion, perioperative probiotic treatment can reduce the rate of postoperative septicemia and is associated with reduced serum zonulin concentrations in patients undergoing colectomy. We propose a new model of probiotics influencing intestinal permeability via a CP (Figure 3 ). Postoperative serum zonulin concentrations could be an early biomarker of septicemia. We recommend the preoperative oral intake of probiotics combined with postoperative continued treatment in patients who need to undergo colorectal surgery.
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